These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 27371107)

  • 1. Immunomodulators in SLE: Clinical evidence and immunologic actions.
    Durcan L; Petri M
    J Autoimmun; 2016 Nov; 74():73-84. PubMed ID: 27371107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Belimumab: review of use in systemic lupus erythematosus.
    Boyce EG; Fusco BE
    Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biology behind the new therapies for SLE.
    Ermann J; Bermas BL
    Int J Clin Pract; 2007 Dec; 61(12):2113-9. PubMed ID: 17997810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus: Diagnosis and clinical management.
    Fava A; Petri M
    J Autoimmun; 2019 Jan; 96():1-13. PubMed ID: 30448290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Davis LS; Reimold AM
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i100-i113. PubMed ID: 28375452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: vitamin D, immunity and lupus.
    Cutolo M; Otsa K
    Lupus; 2008 Jan; 17(1):6-10. PubMed ID: 18089676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
    Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
    Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
    Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
    Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and systemic lupus erythematosus: Causality and association with disease activity and therapeutics.
    Ho LJ; Wu CH; Luo SF; Lai JH
    Biochem Pharmacol; 2024 Sep; 227():116417. PubMed ID: 38996931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B Cell-Based Treatments in SLE: Past Experience and Current Directions.
    Liossis SC; Staveri C
    Curr Rheumatol Rep; 2017 Nov; 19(12):78. PubMed ID: 29101479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydroxychloroquine and systemic lupus: a reappraisal].
    Costedoat-Chalumeau N; Leroux G; Amoura Z; Piette JC
    Rev Med Interne; 2008 Sep; 29(9):735-7. PubMed ID: 17618016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus and risk of infection.
    Barber MRW; Clarke AE
    Expert Rev Clin Immunol; 2020 May; 16(5):527-538. PubMed ID: 32478627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3
    Marinho A; Carvalho C; Boleixa D; Bettencourt A; Leal B; Guimarães J; Neves E; Oliveira JC; Almeida I; Farinha F; Costa PP; Vasconcelos C; Silva BM
    Immunol Res; 2017 Feb; 65(1):197-206. PubMed ID: 27423437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus.
    Martínez T; Garcia-Robledo JE; Plata I; Urbano MA; Posso-Osorio I; Rios-Serna LJ; Barrera MC; Tobón GJ
    Autoimmun Rev; 2019 Mar; 18(3):279-286. PubMed ID: 30639648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics in SLE: the current status.
    Rajadhyaksha AG; Mehra S; Nadkar MY
    J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; García M; Espinosa G; Cabezas-Rodríguez I; Mitjavila F; González-León R; Sopeña B; Perales I; Pinilla B; Rodríguez-Carballeira M; López-Dupla JM; Callejas JL; Castro A; Tolosa C; Sánchez-García ME; Pérez-Conesa M; Navarrete-Navarrete N; Rodríguez AP; Herranz MT; Pallarés L;
    Clin Exp Rheumatol; 2016; 34(3):466-72. PubMed ID: 26940538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.